Dirk Spitzer
Medical University of South Carolina(US)Washington University in St. Louis(US)MUSC Hollings Cancer Center(US)Jewish Hospital(US)
Publications by Year
Research Areas
Pharmacological Receptor Mechanisms and Effects, Cancer therapeutics and mechanisms, Ferroptosis and cancer prognosis, Cancer, Lipids, and Metabolism, Cell death mechanisms and regulation
Most-Cited Works
- → C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy(2007)447 cited
- → Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site(2011)295 cited
- → Properdin Can Initiate Complement Activation by Binding Specific Target Surfaces and Providing a Platform for De Novo Convertase Assembly(2007)278 cited
- → New roles for the major human 3′-5′ exonuclease TREX1 in human disease(2008)133 cited
- → Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation(2010)99 cited
- → The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine(2010)78 cited